|
| |
 |
| |
|
 |
|
A multicenter, randomized controlled clinical trial, that
will compare the fluocinolone acetonide implant to standard
systemic therapy for the treatment of patients with
non-infectious intermediate uveitis, posterior uveitis, or panuveitis.
|
|
|
|
The MUST Trial opened in December 2005. We are currently enrolling patients with uveitis. To find a participating Center near you, click here.
|
|
|
| |
|
|
|
|
